These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35445692)

  • 1. Invited Commentary: Conducting and Emulating Trials to Study Effects of Social Interventions.
    Rojas-Saunero LP; Labrecque JA; Swanson SA
    Am J Epidemiol; 2022 Jul; 191(8):1453-1456. PubMed ID: 35445692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Designing observational studies by target trial emulation].
    van Gelder MMHJ; Rodwell L; Roes KCB
    Ned Tijdschr Geneeskd; 2023 Nov; 167():. PubMed ID: 37994775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
    Colditz GA
    Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emulating a Randomised Controlled Trial With Observational Data: An Introduction to the Target Trial Framework.
    Kutcher SA; Brophy JM; Banack HR; Kaufman JS; Samuel M
    Can J Cardiol; 2021 Sep; 37(9):1365-1377. PubMed ID: 34090982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invited Commentary: Making Causal Inference More Social and (Social) Epidemiology More Causal.
    Jackson JW; Arah OA
    Am J Epidemiol; 2020 Mar; 189(3):179-182. PubMed ID: 31573030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emulating a Target Trial of Interventions Initiated During Pregnancy with Healthcare Databases: The Example of COVID-19 Vaccination.
    Hernández-Díaz S; Huybrechts KF; Chiu YH; Yland JJ; Bateman BT; Hernán MA
    Epidemiology; 2023 Mar; 34(2):238-246. PubMed ID: 36722806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining and Identifying Per-protocol Effects in Randomized Trials.
    Rudolph JE; Naimi AI; Westreich DJ; Kennedy EH; Schisterman EF
    Epidemiology; 2020 Sep; 31(5):692-694. PubMed ID: 32740471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invited Commentary: Treatment Drop-in-Making the Case for Causal Prediction.
    Sperrin M; Diaz-Ordaz K; Pajouheshnia R
    Am J Epidemiol; 2021 Oct; 190(10):2015-2018. PubMed ID: 33595073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invited Commentary: Machine Learning in Causal Inference-How Do I Love Thee? Let Me Count the Ways.
    Balzer LB; Petersen ML
    Am J Epidemiol; 2021 Aug; 190(8):1483-1487. PubMed ID: 33751059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Producing Change to Understand the Social Determinants of Health: The Promise of Experiments for Social Epidemiology.
    Berkman LF; Avendano M; Courtin E
    Am J Epidemiol; 2023 Nov; 192(11):1835-1841. PubMed ID: 35943205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emulating Target Trials to Improve Causal Inference From Agent-Based Models.
    Murray EJ; Marshall BDL; Buchanan AL
    Am J Epidemiol; 2021 Aug; 190(8):1652-1658. PubMed ID: 33595053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contextualizing single-arm trials with real-world data: An emulated target trial comparing therapies for neovascular age-related macular degeneration.
    Thomas DS; Lee AY; Müller PL; Schwartz R; Olvera-Barrios A; Warwick AN; Patel PJ; Heeren TFC; Egan C; Taylor P; Tufail A;
    Clin Transl Sci; 2021 May; 14(3):1166-1175. PubMed ID: 33421321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available.
    Hernán MA; Robins JM
    Am J Epidemiol; 2016 Apr; 183(8):758-64. PubMed ID: 26994063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invited Commentary: The Promise and Pitfalls of Causal Inference With Multivariate Environmental Exposures.
    Zigler CM
    Am J Epidemiol; 2021 Dec; 190(12):2658-2661. PubMed ID: 34079988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invited Commentary: Cross-Sectional Studies and Causal Inference-It's Complicated.
    Barnett TA; Koushik A; Schuster T
    Am J Epidemiol; 2023 Apr; 192(4):517-519. PubMed ID: 36722176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Causal analyses of existing databases: no power calculations required.
    Hernán MA
    J Clin Epidemiol; 2022 Apr; 144():203-205. PubMed ID: 34461211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to letter to the editor from Dr Rahman Shiri: The challenging topic of suicide across occupational groups.
    Niedhammer I; Milner A; Witt K; Klingelschmidt J; Khireddine-Medouni I; Alexopoulos EC; Toivanen S; Chastang JF; LaMontagne AD
    Scand J Work Environ Health; 2018 Jan; 44(1):108-110. PubMed ID: 29218357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invited Commentary: The Prevalent New-User Design in Pharmacoepidemiology-Challenges and Opportunities.
    Filion KB; Yu YH
    Am J Epidemiol; 2021 Jul; 190(7):1349-1352. PubMed ID: 33350439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invited Commentary: Dealing With the Inevitable Deficiencies of Bias Analysis-and All Analyses.
    Greenland S
    Am J Epidemiol; 2021 Aug; 190(8):1617-1621. PubMed ID: 33778862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Causal inference from randomized trials in social epidemiology.
    Kaufman JS; Kaufman S; Poole C
    Soc Sci Med; 2003 Dec; 57(12):2397-409. PubMed ID: 14572846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.